Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-31

Clinical Trial Update: Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and immunogenicity of co-administered Na-GST-1 and Na-APR-1 hookworm vaccine candidates in Gabonese adults. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Na-APR-1 (aspartic protease-1 from Necator americanus)
  • Na-GST-1 (GST-1)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hookworm Infection, Hookworm Disease | Phase 1 | Status: COMPLETED